Project Grant R35GM154998

Award Date 6/15/24
Completion Date 4/30/29
Dollars Obligated $1.1M
Federal Grant Program
93.859
Assistance Type
Project Grant
Place of Performance
Lee, NH 03824, USA
Similar Awards
This $406,250 Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) supports research at the University of Pennsylvania aimed at implementing the nascent extracellular matrix (ECM) into models of dynamic cell-ECM interactions. The overarching goal is to develop improved in vitro systems that better represent complex tissue environments and enable more translatable discoveries, including for drug testing...
This three-year, $681,444 National Science Foundation project grant supports collaborative research to develop tumor-mimetic collagen hydrogels for testing the role of structural cues on cancer cell migration. The Division of Chemical, Bioengineering, Environmental, and Transport Systems awarded the funding under the Engineering program (CFDA 47.041), which aims to foster innovation and excellence in engineering research. The Rochester Institute of Technology will receive the award to create a...
This $483,492 Project Grant awarded by the National Science Foundation's Engineering program to the University of Maryland, College Park, aims to develop biomaterial tools for investigating how extracellular matrix (ECM) ligands influence the function of macrophage immune cells. The 5-year project will leverage polyethylene glycol-based biomaterials with known peptide-derived ECM ligands to quantify the impact of ECM ligand-integrin receptor interactions on macrophage activation. The research...
This National Science Foundation (NSF) Integrative Activities (CFDA 47.083) project grant, awarded to the University of Maine (UMaine) in the amount of $235,977, aims to develop a new class of biomimetic hydrogels for tissue engineering and stem cell therapy applications. The project will establish a long-term partnership between UMaine and the Molecular Foundry at Lawrence Berkeley National Laboratory to support a UMaine graduate student in gaining expertise in the synthesis and...
This $448,150 Project Grant awarded by the National Science Foundation (NSF) Biological Sciences program (CFDA 47.074) aims to develop a DNA-based toolbox for the rapid and precise modulation of cell membrane protein-protein interactions (PPIs). The goal is to establish a modular approach using antibodies and aptamers to enable targeted DNA barcoding of cell membrane proteins, particularly receptor tyrosine kinases. This will allow for the controlled stabilization of specific PPI pairs on living...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) is providing $406,250.00 to The Trustees of the University of Pennsylvania to leverage protein-engineered biomaterials and bioorthogonal chemistries to elucidate the role of non-elastic matrix properties in regulating cell fate. The project aims to develop new chemistries and hydrogel materials that enable simultaneous, independent, and...
This $1,000,000 National Science Foundation project grant will fund the Reproducible Cells and Organoids via Directed-Differentiation Encoding (RECODE) project at the University of Michigan from November 1, 2022 to October 31, 2026. The project aims to employ innovative biophysical, data-driven, and synthetic gene circuit engineering methods to better understand how adult human mesenchymal stem cells transform into chondrocytes, the cells that form cartilage. Specifically, the researchers will...
This Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), aims to develop injectable alginate hydrogels containing peptides that mimic insulin-like growth factor 1 (IGF-1) and promote cell adhesion. The goal is to enhance the therapeutic potential of mesenchymal stem cells (MSCs) for intervertebral disc (IVD) repair. The $752,620 award, spanning...
This National Science Foundation (NSF) Engineering (CFDA 47.041) project grant award of $349,999 aims to engineer a biomaterial platform to investigate how the extracellular matrix (ECM) influences airway basal stem cell (BC) self-renewal and differentiation. The research will utilize poly(ethylene glycol)-based hydrogels to precisely control ECM composition and stiffness, which are limitations of current models like air-liquid interface cultures and 3D organoids. The interdisciplinary effort...
The National Science Foundation (NSF) awarded a $419,934 CAREER grant titled "HIGH-THROUGHPUT MULTI-AXIAL TENSION-INDUCING DNA ORIGAMI DEVICE FOR INVESTIGATING MECHANOSENSITIVE SIGNALING PATHWAYS AND PROTEIN STRUCTURES UNDER DEFINED TENSION" to Arizona State University's Division (doing business as Orspa) on February 1, 2024. The 5-year project will develop a novel "MAESTRO" device that leverages DNA origami to apply controlled mechanical tension to individual integrin...

USING DNA HYDROGELS TO MIMIC, EXPLOIT, AND FUNDAMENTALLY INVESTIGATE EXTRACELLULAR MATRICES - PROJECT SUMMARY SYNTHETIC HYDROGEL BIOMATERIALS HOLD GREAT POTENTIAL AS CELL CULTURE SCAFFOLDS, BUT THEIR COMPLEXITY FALLS SHORT OF MIMICKING THE INTRICACIES OF BIOLOGICAL SYSTEMS, LIMITING THEIR CLINICAL EFFICACY. TO OVERCOME THIS, THE GOAL OF THIS MIRA APPLICATION IS TO DEVELOP A VERSATILE, DNA-BASED SYNTHETIC EXTRACELLULAR MATRIX (ECM) MIMIC THAT CAN BE PRECISELY CONTROLLED, MANIPULATED, AND DEGRADED. THIS RESEARCH SEEKS TO NOT ONLY ENHANCE REGENERATIVE MEDICINE APPLICATIONS BUT ALSO PROVIDE DEEPER INSIGHTS INTO CELL BIOLOGY AND ECM INTERACTIONS. OUR HYPOTHESIS IS THAT BY HARNESSING DNA'S UNIQUE TERTIARY AND QUATERNARY STRUCTURAL PROPERTIES, WE CAN EMULATE COMPLEX MECHANICAL FEATURES OF THE ECM IN A CONTROLLABLE AND ORTHOGONAL MANNER. DNA'S DISTINCT ROLE IN BIOLOGY AND ITS ABSENCE IN NATIVE ECM MAKE IT BIOCOMPATIBLE AND WELL-SUITED AS A SYNTHETIC CELL MATRIX. HOWEVER, COST AND SCALABILITY HAVE LIMITED THE USE OF DNA-BASED ECM MIMICS. FORTUNATELY, RECENT ADVANCEMENTS IN LARGE-SCALE PRODUCTION OF CGMP-GRADE DSDNA FOR VACCINES HAVE MADE IT DRAMATICALLY MORE ACCESSIBLE AND PROVIDE A STARTING MATERIAL RIPE FOR RAPID CLINICAL TRANSLATION. WE HAVE ALREADY MADE SIGNIFICANT PROGRESS IN PRODUCING HIGH-PURITY DSDNA AND DEVELOPING DNA-BASED HYDROGELS WITH ECM-LIKE PROPERTIES, INCLUDING NON-LINEAR ELASTICITY AND TUNABLE VISCOELASTICITY. THESE HYDROGELS EXHIBIT PROMISE IN ENCAPSULATING CELLS WITHOUT CYTOTOXICITY AND OFFER THE POTENTIAL FOR CONTROLLING TISSUE-MIMETIC PROPERTIES. OUR FUTURE RESEARCH PROGRAM IS DIVIDED INTO THREE THRUSTS. IN THRUST 1, WE AIM TO DEVELOP DNA HYDROGELS WITH TUNABLE ECM-MIMETIC PROPERTIES AND STUDY THEIR INTERACTIONS WITH EMBEDDED CELLS. WE WILL INDEPENDENTLY EXPLORE TUNING NON-LINEAR ELASTICITY AND VISCOELASTICITY, PROVIDING VALUABLE INSIGHTS INTO CELL BEHAVIOR UNDER HARD TO EMULATE MECHANICAL CONDITIONS. THRUST 2 FOCUSES ON DYNAMIC MODULATION OF DNA HYDROGEL PROPERTIES, ALLOWING FOR THE CONTROLLABLE ACTUATION OF CHANGES IN ELASTICITY AND VISCOELASTICITY OVER TIME. THIS APPROACH MIMICS THE DYNAMIC MANIPULATION OF ECM DURING BIOLOGICAL PROCESSES SUCH AS DISEASE ONSET OR HEALING AND AIMS TO PROVIDE A DEEPER UNDERSTANDING OF CELL RESPONSES TO CHANGING MECHANICAL PROPERTIES. IN THRUST 3, WE INVESTIGATE THE EXPRESSION AND RELEASE OF SMALL PROTEINS AND GROWTH FACTORS DIRECTLY FROM THE DNA MATRIX, ENHANCING NUTRIENT TRANSPORT AND ENABLING FINAL RELEASE FROM THE SYNTHETIC MATRIX. OVERALL, THIS RESEARCH PROGRAM AIMS TO DEMONSTRATE THE BROAD UTILITY OF DNA-BASED HYDROGELS AS ECM MIMICS APPLICATIONS IN REGENERATIVE MEDICINE AND FUNDAMENTAL STUDIES OF BIOPHYSICS. THESE HYDROGELS HAVE THE POTENTIAL TO REVOLUTIONIZE OTHER FIELDS, FROM TISSUE ENGINEERING TO DRUG DELIVERY, BIOSENSING, AND BEYOND.

Posted 6/11/24, 12:00 AM